Lemaitre Vascular [LMAT] vs AptarGroup [ATR] Detailed Stock Comparison
Lemaitre Vascular
NASDAQ
Loading...
AptarGroup
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lemaitre Vascular wins in 7 metrics, AptarGroup wins in 13 metrics, with 0 ties. AptarGroup appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lemaitre Vascular | AptarGroup | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 45.01 | 24.35 | AptarGroup |
| Price-to-Book Ratio | 5.76 | 3.43 | AptarGroup |
| Debt-to-Equity Ratio | 51.25 | 43.12 | AptarGroup |
| PEG Ratio | 42.53 | 23.74 | AptarGroup |
| EV/EBITDA | 30.14 | 12.88 | AptarGroup |
| Profit Margin (TTM) | 20.08% | 10.84% | Lemaitre Vascular |
| Operating Margin (TTM) | 25.13% | 15.17% | Lemaitre Vascular |
| EBITDA Margin (TTM) | 25.13% | 15.17% | Lemaitre Vascular |
| Return on Equity | 13.81% | 15.26% | AptarGroup |
| Return on Assets (TTM) | 7.28% | 7.10% | Lemaitre Vascular |
| Free Cash Flow (TTM) | $37.16M | $349.22M | AptarGroup |
| Dividend Yield | 0.98% | 0.90% | Lemaitre Vascular |
| 1-Year Return | 10.17% | -2.22% | Lemaitre Vascular |
| Price-to-Sales Ratio (TTM) | 8.90 | 2.57 | AptarGroup |
| Enterprise Value | $1.96B | $10.29B | AptarGroup |
| EV/Revenue Ratio | 8.33 | 2.85 | AptarGroup |
| Gross Profit Margin (TTM) | 70.02% | 37.99% | Lemaitre Vascular |
| Revenue per Share (TTM) | $10 | $54 | AptarGroup |
| Earnings per Share (Diluted) | $2.05 | $5.78 | AptarGroup |
| Beta (Stock Volatility) | 0.79 | 0.57 | AptarGroup |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lemaitre Vascular vs AptarGroup Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | -2.10% | 13.87% | 9.97% | 13.23% | -6.26% | 0.89% |
| AptarGroup | 0.19% | -0.42% | -12.06% | -8.22% | -1.77% | -8.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lemaitre Vascular | 10.17% | 68.46% | 225.16% | 578.03% | 1,438.00% | 1,330.70% |
| AptarGroup | -2.22% | 26.71% | 18.79% | 101.45% | 236.32% | 461.43% |
Performance & Financial Health Analysis: Lemaitre Vascular vs AptarGroup
| Metric | LMAT | ATR |
|---|---|---|
| Market Information | ||
| Market Cap | $2.09B | $9.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 186,980 | 585,720 |
| 90 Day Avg. Volume | 139,390 | 417,123 |
| Last Close | $92.28 | $140.75 |
| 52 Week Range | $71.42 - $109.58 | $130.85 - $178.03 |
| % from 52W High | -15.79% | -20.94% |
| All-Time High | $109.58 (Nov 25, 2024) | $178.03 (Nov 11, 2024) |
| % from All-Time High | -15.79% | -20.94% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.06% |
| Quarterly Earnings Growth | 0.17% | 0.24% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.11% |
| Operating Margin (TTM) | 0.25% | 0.15% |
| Return on Equity (TTM) | 0.14% | 0.15% |
| Debt to Equity (MRQ) | 51.25 | 43.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.02 | $41.04 |
| Cash per Share (MRQ) | $14.11 | $2.58 |
| Operating Cash Flow (TTM) | $58.76M | $616.20M |
| Levered Free Cash Flow (TTM) | $37.70M | $291.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.98% | 0.90% |
| Last 12-Month Dividend | $0.92 | $1.35 |
Valuation & Enterprise Metrics Analysis: Lemaitre Vascular vs AptarGroup
| Metric | LMAT | ATR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 45.01 | 24.35 |
| Forward P/E | 42.53 | 23.74 |
| PEG Ratio | 42.53 | 23.74 |
| Price to Sales (TTM) | 8.90 | 2.57 |
| Price to Book (MRQ) | 5.76 | 3.43 |
| Market Capitalization | ||
| Market Capitalization | $2.09B | $9.27B |
| Enterprise Value | $1.96B | $10.29B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.33 | 2.85 |
| Enterprise to EBITDA | 30.14 | 12.88 |
| Risk & Other Metrics | ||
| Beta | 0.79 | 0.57 |
| Book Value per Share (MRQ) | $16.02 | $41.04 |
Financial Statements Comparison: Lemaitre Vascular vs AptarGroup
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LMAT | ATR |
|---|---|---|
| Revenue/Sales | $59.87M | $887.31M |
| Cost of Goods Sold | $18.45M | $550.89M |
| Gross Profit | $41.42M | $336.41M |
| Research & Development | $4.10M | N/A |
| Operating Income (EBIT) | $12.63M | $115.49M |
| EBITDA | $18.08M | $186.15M |
| Pre-Tax Income | $14.24M | $106.02M |
| Income Tax | $3.23M | $27.35M |
| Net Income (Profit) | $11.01M | $78.66M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LMAT | ATR |
|---|---|---|
| Cash & Equivalents | $25.34M | $125.84M |
| Total Current Assets | $408.11M | $1.51B |
| Total Current Liabilities | $24.75M | $1.21B |
| Long-Term Debt | $182.73M | $612.02M |
| Total Shareholders Equity | $347.57M | $2.55B |
| Retained Earnings | $151.58M | $2.42B |
| Property, Plant & Equipment | $41.34M | $66.57M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LMAT | ATR |
|---|---|---|
| Operating Cash Flow | $5.69M | $100.50M |
| Capital Expenditures | $-1.38M | $79,000 |
| Free Cash Flow | $7.66M | $23.41M |
| Debt Repayment | N/A | $-4.55M |
| Common Stock Repurchase | N/A | $-80.00M |
Short Interest & Institutional Ownership Analysis
| Metric | LMAT | ATR |
|---|---|---|
| Shares Short | 1.38M | 901,388 |
| Short Ratio | 9.42 | 2.53 |
| Short % of Float | 0.08% | 0.02% |
| Average Daily Volume (10 Day) | 186,980 | 585,720 |
| Average Daily Volume (90 Day) | 139,390 | 417,123 |
| Shares Outstanding | 22.55M | 66.50M |
| Float Shares | 20.69M | 65.33M |
| % Held by Insiders | 0.09% | 0.01% |
| % Held by Institutions | 0.95% | 0.96% |
Dividend Analysis & Yield Comparison: Lemaitre Vascular vs AptarGroup
| Metric | LMAT | ATR |
|---|---|---|
| Last 12-Month Dividend | $0.92 | $1.35 |
| Last 12-Month Dividend Yield | 0.98% | 0.90% |
| 3-Year Avg Annual Dividend | $0.68 | $1.50 |
| 3-Year Avg Dividend Yield | 0.23% | 0.32% |
| 3-Year Total Dividends | $2.04 | $4.51 |
| Ex-Dividend Date | Aug 21, 2025 | Feb 05, 2025 |